Indefinite Delivery Contract 75D30121D11356
Award Date
6/25/21
Last Date to Order
6/30/22
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Sanofi Pasteur Inc. was awarded an indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention to supply various adult vaccines. The contract is a multiple award with a potential value of $42.4 million and a period of performance from July 1, 2023 through June 30, 2024. The originating solicitation sought proposals for contracts to provide approximately 1.5 to 3 million doses of 12 different adult vaccines in support of the CDC's...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), awarded a multiple-award Indefinite Delivery Contract to Sanofi Pasteur Inc. to purchase 12 standard adult vaccines. The $42.2 million contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and does not have any set-aside designation. The solicitation required offerors to provide minimum and maximum order quantities ranging from 100 to 1,000,000 doses...
The Centers for Disease Control and Prevention awarded a multiple-award indefinite delivery contract to Sanofi Pasteur Inc. to procure adult vaccines. With a potential value of $37.2 million, this vehicle provides for the delivery of various vaccine products and services over its one-year ordering period through June 2022. The contract supports the CDC's adult immunization programs by establishing competitive pricing for items like influenza, pneumococcal, tetanus-diphtheria-acellular pertussis,...
The Centers for Disease Control and Prevention (CDC) has awarded a 5-year, multiple-award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the purchase of various adult vaccines. The contract has a ceiling value of $54,975,837.60 and covers the period from July 1, 2024 to June 30, 2025, with the possibility of subsequent option years. As the prime contractor, Sanofi Pasteur Inc. will provide a range of vaccines including Hepatitis A, Hepatitis B, Hepatitis A&B combination,...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under a competitive solicitation to purchase standard adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $85.6 million. Merck Sharp & Dohme LLC was awarded one of these contracts as the prime contractor. The contracts enable the CDC to order 12 types of adult vaccines for delivery within 15 business days....
The Centers for Disease Control and Prevention awarded multiple indefinite-delivery, indefinite-quantity contracts valued at up to $25,350,000 to supply adult vaccines for the period of July 1, 2023 through June 30, 2024. The prime contractor is VBI Vaccines (Delaware) Inc. The contracts aim to procure minimum and maximum quantities of 12 adult vaccines, including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles, mumps and rubella,...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Merck Sharp & Dohme LLC for adult vaccines. The contracts have a potential value of $83,485,760 and a period of performance from July 1, 2021 to June 30, 2022. Merck will provide 13 standard adult vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, measles/mumps/rubella, meningococcal conjugate, human papillomavirus, and...
The Centers for Disease Control and Prevention awarded Sanofi Pasteur Inc. a multiple-award indefinite delivery contract with a potential value of $67,076,901.90 to procure adult flu vaccines for 2023-2024. No set-aside was used for this award. Under the terms of the contract, the awardee will deliver flu vaccines to the CDC through the period ending February 28, 2024. The solicitation sought to procure adult flu vaccines in support of the CDC's efforts to prevent the spread of influenza. As the...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a multiple award, indefinite delivery contract to Sanofi Pasteur Inc. to provide up to $1.683 billion in pediatric vaccines for the CDC's Vaccines for Children program. This 12-month contract enables the CDC and its Immunization Awardees to order a range of 20 standard pediatric vaccines including DTaP, IPV, Hepatitis A/B, Hib, HPV, MMR, MCV4, PCV13, Rotavirus, Td, Tdap, and Varicella vaccines....
Sanofi Pasteur Inc. was awarded a single-award indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention potentially valued at $64 million. The contract provides for the delivery of seasonal influenza vaccines to support public health programs as outlined in Section 317(j) of the Public Health Service Act. Performance will occur at the prime contractor's manufacturing facility in Swiftwater, Pennsylvania or other locations as needed to...